摘要
Synaptic loss in the brain correlates well with disease severity in Alzheimer disease (AD). Deficits in brain-derived neurotrophic factor/tropomyosin-receptor-kinase B (TrkB) signaling contribute to the synaptic dysfunction of AD. We have recently identified 7,8-dihydroxyflavone (7,8-DHF) as a potent TrkB agonist that displays therapeutic efficacy toward various neurological diseases. Here we tested the effect of 7,8-DHF on synaptic function in an AD model both in vitro and in vivo. 7,8-DHF protected primary neurons from A beta-induced toxicity and promoted dendrite branching and synaptogenesis. Chronic oral administration of 7,8-DHF activated TrkB signaling and prevented Ab deposition in transgenic mice that coexpress five familial Alzheimer's disease mutations (5XFAD mice). Moreover, 7,8-DHF inhibited the loss of hippocampal synapses, restored synapse number and synaptic plasticity, and prevented memory deficits. These results suggest that 7,8-DHF represents a novel oral bioactive therapeutic agent for treating AD.
| 源语言 | 英语 |
|---|---|
| 页(从-至) | 638-650 |
| 页数 | 13 |
| 期刊 | Neuropsychopharmacology |
| 卷 | 39 |
| 期 | 3 |
| DOI | |
| 出版状态 | 已出版 - 2月 2014 |
基金资助
This work was supported by a grant from the National Institute of Health (RO1, DC010204) to K Ye, the NIH/NIAP50 ADRC center grant to both K Ye and D Weinshenker, and a grant from the National Natural Science Foundation of China (No. 81100958) to Z Zhang.
关键词
- 7,8-Dihydroxyflavone
- Synapse
- TrkB
- Alzheimer's disease
- neuroprotection
收录
- Scopus
- SCIE
学术指纹
探究 '7,8-Dihydroxyflavone Prevents Synaptic Loss and Memory Deficits in a Mouse Model of Alzheimer's Disease' 的科研主题。它们共同构成独一无二的学术指纹。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver